StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.03+0.05 (+2.53%)

Close on Nov 18, 2026Market cap $164.96MP/E –Yield –

Eledon Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Eledon Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2016 was -$4.93M. For fiscal 2016 it was -$4.93M. The highest annual figure on record is -$4.93M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2016Dec 31, 2016-$4.93M–
FY2015Dec 31, 2015-$41.80M–
FY2014Dec 31, 2014-$21.15M–
FY2013Dec 31, 2013-$15.50M–
FY2012Dec 31, 2012-$9.34M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2016Dec 31, 2016-$1.28M–
Q3 FY2016Sep 30, 2016-$1.48M–

More Eledon Pharmaceuticals figures

See a number that looks wrong?